Search Form
First, enter a politician or zip code
Now, choose a category
 

Greg Walden's Public Statements

Office: U.S. House (OR) - District 2, Republican
On The Ballot: Running, Republican for U.S. House - District 2
Date Title
April 26, 2018 Greg Walden on opioid crisis: "It is time for us to act"
April 26, 2018 Greg Walden announces Oregon collection sites for excess opioids, prescription pills
April 25, 2018 McMorris Rodgers Bill To Protect Columbia And Snake River Dams Passes House
April 18, 2018 Opioid Epidemic
April 18, 2018 E&C Leaders Comment on DEA Action to Help Combat the Opioid Crisis
April 12, 2018 Greg Walden on combating opioid crisis: "We must continue to push forward"
April 12, 2018 #SubHealth Reviews Medicare and Medicaid Solutions to Help Combat the Opioid Crisis
April 11, 2018 Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Walden, Hearing on Combating the Opioid Crisis: Improving the Ability of Medicare and Medicaid to Provide Care for Patients
March 23, 2018 Greg Walden supports legislation to increase school safety
March 21, 2018 #SubHealth Reviews Prevention and Public Health Solutions to Combat the Opioid Crisis
March 18, 2018 Walden, Burgess, and Harper on Trump Administration's Plan to Combat the Opioid Crisis
March 7, 2018 Letters to the U.S. Olympic Committee, 48 National Governing Bodies, and Michigan State University on Sexual Abuse in Organized Sports - Sexual Abuse within US Olympic Community
March 6, 2018 Walden, Burgess, and Harper Comment on New CDC Report on Growing Concerns of Opioid Crisis
March 1, 2018 Greg Walden on efforts to combat the opioid crisis: "The rubber has really hit the road"
Feb. 28, 2018 Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Walden, Hearing on Combating the Opioid Crisis: Helping Communities Balance Enforcement and Patient Safety
Feb. 28, 2018 Connection To Congress: Combating the opioid crisis
Feb. 28, 2018 Greg Walden on opioid epidemic: "We have to act"
Feb. 16, 2018 Walden, Blackburn on President Trump Signing Kari's Law
Feb. 8, 2018 House, Senate Health Committee Leaders Release Discussion Draft of FDA Animal Drug User Fees Reauthorization
Feb. 8, 2018 House, Senate Health Committee Leaders Release Discussion Draft of FDA Animal Drug User Fees Reauthorization
Feb. 6, 2018 DeGette and other Energy and Commerce Committee Leaders Call on DEA to "Stop Playing Games"
Jan. 26, 2018 Letter to Ms. Kerry Perry, President CEO, USA Gymnastics, Mr. Brian Breslin, Chairman, MSU Board of Trustees, Mr. Scott Blackmun, CEO, US Olympic Committee, Mr. Steve McNally, Executive Director, USA Taekwondo, and Mr. Tim Hinchey, President and CEO, USA Swimming - Investigate Sexual Abuse in Organized Sports
Dec. 12, 2017 #SubOversight Reviews Patient Brokering and Treatment Fraud Intensified by Opioid Crisis
Dec. 12, 2017 Hearing of the House Committee on Energy and Commerce - Opening Statement of Rep. Greg Walden, Hearing on "Examining Concerns of Patient Brokering and Addiction Treatment Fraud"
Dec. 6, 2017 Letter to Prime Minister Hailemariam Desalegn - Senators Blunt, Klobuchar, Young Lead Bipartisan, Bicameral Letter to Ethiopian Prime Minister on Adoptions
Dec. 5, 2017 E&C Leaders on the IOC Barring Russia from the 2018 Winter Olympic Games
Oct. 27, 2017 Letter to the Hon. Jeff Sessions, Attorney General - Guidance on the Ensuring Patient Access and Effective Drug Enforcement Act
Oct. 27, 2017 Letter to the Hon. Jeff Sessions, Attorney General - Guidance on the Ensuring Patient Access and Effective Drug Enforcement Act
Oct. 26, 2017 E&C Leaders on President Trump's Public Health Emergency Declaration for #OpioidCrisis
Oct. 25, 2017 Walden Grills DEA on Lack of Cooperation, Response on Committee Investigation
Oct. 25, 2017 Walden Grills DEA on Lack of Cooperation, Response on Committee Investigation
Oct. 13, 2017 Letter to Robert Patterson, Acting Administrator of the Drug Enforcement Administration - Regarding Alleged Pill Dumping in West Virginia
Oct. 11, 2017 Letter to the Hon. Thomas Brandon, Acting Director of the Bureau of Alcohol, Tobacco, Firearms, and Explosives - Bipartisan Letter to Ban Bump Stocks
Oct. 11, 2017 50+ Members Testify Before #SubHealth, Sharing Stories and Legislative Ideas to Combat #OpioidCrisis
Sept. 26, 2017 Letter to Joseph Mastandrea, Chairman of the Board of Miami-Luken, Inc. and Michael Faul, President and Chief Executive Officer of Miami-Luken, Inc. - Congress Members Expand Bipartisan Investigation into Alleged Pill Dumping in West Virginia Amid Opioid Crisis
Sept. 5, 2017 Greg Walden statement regarding the Deferred Action for Childhood Arrivals (DACA) program
July 13, 2017 Greg Walden calls for urgency in fight against opioid abuse in Oregon
July 13, 2017 Letter to the Hon. Thomas E. Price, Secretary of the Department of Health and Human Services - Patient Brokering in Addiction Treatment Centers
July 12, 2017 #SubOversight Examines the Opioid Crisis at the State Level
June 29, 2017 McMorris Rodgers, Herrera Beutler, Newhouse, Schrader, and Walden Introduce Legislation to Address FCRPS Biological Opinion
June 14, 2017 Statement from E&C Chairman Walden
May 8, 2017 Letter to AmerisourceBergen Corporation, CardinalHealth, McKesson Corporation and the Drug Enforcement Administration - Alleged Pill Dumping in West Virginia
April 20, 2017 Greg Walden applauds grant funding to combat opioid addiction in Oregon
April 19, 2017 HHS to Issue First Round of Opioid Grants from 21st Century Cures Act
March 29, 2017 E&C Leaders Comment on President Trump's Executive Action to Address Opioid Epidemic
March 21, 2017 Hearing of the Oversight and Investigations Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Walden, Hearing on Fentanyl: The Next Wave of the Opioid Crisis
Feb. 28, 2017 Hearing of the Oversight and Investigation Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Walden, Hearing on Ways to Improve and Strengthen the International Anti-Doping System
Feb. 28, 2017 #SubOversight Examines International Anti-Doping System With All-Star Panel
Feb. 28, 2017 #SubOversight Examines International Anti-Doping System With All-Star Panel
Feb. 23, 2017 Letter to Mr. Kemp Chester, Acting Director of the the Office of National Dug Control Policy - Provide Assistance in Questioning all Federal Agencies on Plans to Address Fentanyl
Skip to top

Help us stay free for all your Fellow Americans

Just $5 from everyone reading this would do it.

Thank You!

You are about to be redirected to a secure checkout page.

Please note:

The total order amount will read $0.01. This is a card processor fee. Please know that a recurring donation of the amount and frequency that you selected will be processed and initiated tomorrow. You may see a one-time charge of $0.01 on your statement.

Continue to secure page »

Back to top